Ladizinski, Barry
AbbVie (United States)
3 papers on CoChatORCID 0000-0001-7459-0830
Most cited papers
- Verified
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
Blauvelt, A., Teixeira, H. D., Simpson, E. L., Costanzo, A., De Bruin-Weller, M., Barbarot, S., Prajapati, V. H., Lio, P., Hu, X., Wu, T., et al. (2021) · JAMA Dermatology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 516
- Verified
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Reich, K., Teixeira, H. D., de Bruin-Weller, M., Bieber, T., Soong, W., Kabashima, K., Werfel, T., Zeng, J., Huang, X., Hu, X., et al. (2021) · The Lancet
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 402
- Verified
Widespread Use of Toxic Skin Lightening Compounds: Medical and Psychosocial Aspects
Ladizinski, B., Mistry, N., & Kundu, R. V. (2011) · Dermatologic Clinics
melanin and skin pigmentationDermatologic Treatments and Research
Cited by 156
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free